An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Henry Schein Announces the Passing of Board Member E. Dianne Rekow
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
Henry Schein, Inc. (Nasdaq: HSIC) announced the passing of Dr. E. Dianne Rekow, a Board member since 2014 and a leader in digital dentistry. Recognized for her contributions to the field, Dr. Rekow served on the Strategic Advisory Committee and was a prominent figure in aesthetic and restorative dentistry. Her extensive academic background included roles at King's College London and NYU, along with over 100 publications and several patents. This loss may impact the company’s strategic direction given her expertise in digital solutions for dental practices.
Positive
Dr. Rekow's expertise in digital dentistry provided valuable insights to the board.
Her contributions included serving on the Strategic Advisory Committee, enhancing strategic planning.
Negative
The loss of Dr. Rekow may create a gap in leadership regarding digital dentistry advancements.
Concerns may arise over continuity in strategic initiatives tied to her expertise.
MELVILLE, N.Y.--(BUSINESS WIRE)--
Henry Schein, Inc. (Nasdaq: HSIC) announced the passing today of E. Dianne Rekow, DDS, Ph.D., a member of the Company’s Board of Directors since 2014 and a leader in the development of digital dentistry.
E. Dianne Rekow, DDS, Ph.D., a member of the Henry Schein Board of Directors since 2014 and a leader in the development of digital dentistry. (Photo: Business Wire)
“Dianne was an extraordinary board member and an internationally known authority on aesthetic and restorative dentistry as well as one of the early pioneers in digital dentistry,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. “Dianne’s contributions to the Henry Schein board have been many and impactful, including serving as a member of our Strategic Advisory Committee. We will miss her probing spirit, expertise, and comradery.”
Dr. Rekow was also Professor Emeritus and Fellow at King's College London, where she served as Executive Dean of its Dental Institute and Professor of Orthodontics from 2012 through 2016. From 2002 to 2012, Dr. Rekow was a Professor of Orthodontics at New York University (NYU), during which time she was Senior Vice Provost of Engineering Technology at NYU and was Provost of Polytechnic Institute of NYU. She was also a Senior Scholar of the Sante Fe Group, a leading think-tank dedicated to improving life through oral health.
Dr. Rekow was an internationally known authority on the performance of new dental materials, capitalizing on her engineering education. Her teams carried out research into the use of bio-engineered tissue to facilitate bone replacement in individuals disfigured by disease or developmental defects. She held a number of patents in the dental field and is the author of, or contributor to, more than one hundred publications. Dr. Rekow’s career also included serving as President of both the International Association for Dental Research and the American Association of Dental Research. In 2012, she was elected to the Faculty of Dental Surgery of the Royal College of Surgeons in the UK.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.
What was Dr. E. Dianne Rekow's role at Henry Schein?
Dr. Rekow served on the Board of Directors since 2014 and was involved in the Strategic Advisory Committee, focusing on digital dentistry.
How might Dr. Rekow's passing affect Henry Schein's board?
Her passing may create a leadership gap in digital dentistry, potentially impacting strategic initiatives and decisions.
What contributions did Dr. Rekow make to Henry Schein?
Dr. Rekow contributed valuable insights into digital dentistry and served on the Strategic Advisory Committee, enhancing the company's strategic planning.
